Beam Therapeutics, Inc. (BEAM)
24.03
-1.78
(-6.90%)
USD |
NASDAQ |
Nov 12, 16:00
24.20
+0.17
(+0.71%)
After-Hours: 06:32
Beam Therapeutics Shareholders Equity (Quarterly) : 952.67M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 952.67M |
| June 30, 2026 | 1.067B |
| March 31, 2026 | 1.164B |
| December 31, 2025 | 1.238B |
| September 30, 2025 | 966.00M |
| June 30, 2025 | 1.047B |
| March 31, 2025 | 1.123B |
| December 31, 2024 | 733.54M |
| September 30, 2024 | 791.32M |
| June 30, 2024 | 854.09M |
| March 31, 2024 | 913.49M |
| December 31, 2023 | 981.33M |
| September 30, 2023 | 778.94M |
| June 30, 2023 | 811.64M |
| March 31, 2023 | 761.51M |
| December 31, 2022 | 733.47M |
| Date | Value |
|---|---|
| September 30, 2022 | 714.48M |
| June 30, 2022 | 800.16M |
| March 31, 2022 | 829.07M |
| December 31, 2021 | 826.74M |
| September 30, 2021 | 853.81M |
| June 30, 2021 | 548.55M |
| March 31, 2021 | 422.43M |
| December 31, 2020 | 245.56M |
| September 30, 2020 | 200.07M |
| June 30, 2020 | 230.82M |
| March 31, 2020 | 261.39M |
| December 31, 2019 | 100.94M |
| September 30, 2019 | 126.72M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 134.03M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 613.09M |
| Twist Bioscience Corp. | -- |
| Prime Medicine, Inc. | 39.81M |
| Sarepta Therapeutics, Inc. | 1.529B |
| Q32 Bio, Inc. | 287.67M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.269B |
| Total Liabilities (Quarterly) | 316.40M |
| Debt to Equity Ratio | 0.256 |
| Current Ratio | 13.00 |
| Net Debt Paydown Yield | -0.70% |